127 related articles for article (PubMed ID: 15555143)
21. Comparative effectiveness of antipsychotic drugs.
Gupta S
Am J Psychiatry; 2003 Mar; 160(3):591; author reply 592-3. PubMed ID: 12611855
[No Abstract] [Full Text] [Related]
22. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
23. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive ondansetron in schizophrenia--A pilot study.
Hema T; Maran S; Subhashini G
Asian J Psychiatr; 2016 Feb; 19():66-7. PubMed ID: 26957341
[No Abstract] [Full Text] [Related]
25. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
Dervaux A; Cazali J
J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
[No Abstract] [Full Text] [Related]
26. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
27. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
29. Breastfed Infants Exposed to Combined Antipsychotics: Two Case Reports.
Uguz F
Am J Ther; 2016; 23(6):e1962-e1964. PubMed ID: 26539905
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
George S; Cowan C
Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
[No Abstract] [Full Text] [Related]
31. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
32. Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial.
Zhang ZJ; Tong Y; Wang XY; Yao SM; Jin GX; Wang XP
Schizophr Res; 2007 May; 92(1-3):273-5. PubMed ID: 17383858
[No Abstract] [Full Text] [Related]
33. Clozapine augmentation with amisulpride.
Porcelli S; Serretti A; Bianchini O
J Psychiatry Neurosci; 2014 Nov; 39(6):E38-9. PubMed ID: 25340724
[No Abstract] [Full Text] [Related]
34. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
[TBL] [Abstract][Full Text] [Related]
35. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
[TBL] [Abstract][Full Text] [Related]
36. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
37. Prevention of relapse in schizophrenia.
Geddes J
N Engl J Med; 2002 Jan; 346(1):56-8. PubMed ID: 11778005
[No Abstract] [Full Text] [Related]
38. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
39. Combined use of atypical antipsychotics and cognitive-behavioural therapy in schizophrenia.
Duggal HS
Can J Psychiatry; 2002 Nov; 47(9):887-8. PubMed ID: 12500763
[No Abstract] [Full Text] [Related]
40. Effect of neuroleptics on the schizophrenic syndrome.
Meltzer HY
Psychopharmacol Ser; 1987; 3():255-65. PubMed ID: 2881291
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
